P

Inventor

DEL RIO GANCEDO SUSANA

GB12 patents
⚠️ This page may combine multiple inventors who share the name “DEL RIO GANCEDO SUSANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REYNOLDS TOBACCO CO R

3 patents
US10508096B2Dec 17, 2019

Nicotine salts, co-crystals, and salt co-crystal complexes

REYNOLDS TOBACCO CO R12 citations81
US11225468B2Jan 18, 2022

Nicotine salts, co-crystals, and salt co-crystal complexes

REYNOLDS TOBACCO CO R3 citations70
US12180179B2Dec 31, 2024

Nicotine salts, co-crystals, and salt co-crystal complexes

REYNOLDS TOBACCO CO R0 citations59

BECKLEY PSYTECH LTD

2 patents
US11773063B1Oct 3, 2023

Pharmaceutically acceptable salts and compositions thereof

BECKLEY PSYTECH LTD7 citations80
US12264131B2Apr 1, 2025

Pharmaceutically acceptable salts and compositions thereof

BECKLEY PSYTECH LTD0 citations57

RENEO PHARMACEUTICALS INC

2 patents
US11267795B2Mar 8, 2022

Crystalline PPAR-delta agonist

RENEO PHARMACEUTICALS INC4 citations64
US11713301B2Aug 1, 2023

Crystalline PPARδ agonist

RENEO PHARMACEUTICALS INC0 citations53

INFINITY PHARMACEUTICALS INC

1 patent
US9481667B2Nov 1, 2016

Salts and solid forms of isoquinolinones and composition comprising and methods of using the same

INFINITY PHARMACEUTICALS INC4 citations66

KIORA PHARMACEUTICALS GMBH

1 patent
US12209073B2Jan 28, 2025

Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor

KIORA PHARMACEUTICALS GMBH2 citations61

INFLAZOME LTD

1 patent
US10973803B2Apr 13, 2021

Sodium salt of N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazole-3-sulfonamide

INFLAZOME LTD1 citations59

H LUNDBECK AS

1 patent
US12152029B2Nov 26, 2024

Crystalline forms of a MAGL inhibitor

H LUNDBECK AS0 citations56

ESCAPE BIO INC

1 patent
US11535632B2Dec 27, 2022

Solid forms of an S1P-receptor modulator

ESCAPE BIO INC0 citations45